Q3 2025 Earnings Call November 6, 2025 4:30 PM ESTCompany ParticipantsTrip TaylorJohn Treace - Founder, Chairman ...

Treace Medical Concepts, Inc. (NASDAQ: TMCI) Q3 2025 Earnings Call Transcript November 7, 2025 ...

Third quarter 2025 net loss was $ (16.3) million, or $ (0.26) per share, compared to $ (15.4) million, or $ (0.25) per share, for the same period in 2024. Adjusted EBITDA loss was $ (2.6) million in ...

CEO Treace stated, "we are not growing our line the way we anticipated for the year," while also noting case volume growth in ...

Green Bay Packers wide receiver Jayden Reed announced on social media that he had surgery to repair both a broken clavicle and a Jones fracture in his left foot Sept. 16. "Successful foot & clavicle ...

BTIG downgraded Treace Medical (TMCI) to Neutral from Buy without a price target The company’s implied Q4 outlook was “surprisingly bad,” the ...

In orthopedic surgery, robots now guide the scalpel and AI completes the paperwork — and that’s only the beginning. Few people see the change as clearly as J. Paul Schroeppel, MD, who balances life in ...

Consensus $227.17M. The company said, “The Company is revising full-year 2025 revenue guidance to $211 million to $213 million representing growth ...

Foot and ankle surgeons, there’s a new tool on the horizon — and it’s made of something a little different than what’s ...